Genocea Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GNCAQ and buy or sell other stocks, ETFs, and their options commission-free!About GNCAQ
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses.
CEOChip Clark, MBA
CEOChip Clark, MBA
Employees74
Employees74
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2006
Founded2006
Employees74
Employees74
GNCAQ Key Statistics
Market cap5.88K
Market cap5.88K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume955.00
Average volume955.00
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 5.88K, Genocea Biosciences(GNCAQ) trades at $0.00.
Genocea Biosciences(GNCAQ) stock opened on 2026-03-03 at —. The price climbed to — and dipped to —.
Genocea Biosciences(GNCAQ) shares are trading with a volume of 0, against a daily average of 955.
In the last year, Genocea Biosciences(GNCAQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, Genocea Biosciences(GNCAQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own GNCAQ. This list is generated using Robinhood data, and it’s not a recommendation.